(126 days)
Not Found
No
The device is a surgical gown, and the summary focuses on material properties and barrier performance, with no mention of AI or ML.
No.
The device (surgical gown) is intended to protect patients and personnel from the transfer of microorganisms, body fluids, and particulate material, not to treat or cure a disease or medical condition.
No
The device is a surgical gown, which is intended to protect operating room personnel and patients from the transfer of microorganisms, body fluids, and particulate material. It does not diagnose any condition or disease.
No
The device described is a physical surgical gown made of non-woven material and cotton, with performance studies focused on material properties and barrier protection. There is no mention of software components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the surgical gown is for protecting surgical patients and operating room personnel from the transfer of microorganisms, body fluids, and particulate material. This is a barrier function, not a diagnostic one.
- Device Description: The description focuses on the materials, construction, and barrier performance of the gown. There is no mention of any components or functions related to testing samples from the human body.
- Performance Studies and Metrics: The performance studies and metrics evaluate the physical properties and barrier performance of the gown (strength, tear resistance, lint generation, water resistance, sterilization residuals, biocompatibility). These are relevant to a protective garment, not a diagnostic test.
- No mention of analyzing samples: IVD devices are designed to analyze samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. This document does not describe any such function.
Therefore, the surgical gown described is a medical device intended for protection and barrier function, not for in vitro diagnostic testing.
N/A
Intended Use / Indications for Use
Surgical Gowns are intended to be worn by operating room personnel during surgical procedures to protect the surgical patient and operating room personnel from the transfer of microorganisms, body fluids and particulate material. This surgical gown meets the requrements of AAMI Level 3 barrier protection for a surgical gown per ANSI/A AMI PB70:2012 Liquid barrier performance and classification of protective apparel and drapes intended for use in health care facilities (AAMI PB70). The Surgical Gowns are single use, disposable medical devices, provided sterile.
Product codes
FYA
Device Description
The proposed device Surgical Gown is model 40083, its body, sleeve and belt are made of SSMMS non-woven material, and cuff is made of cotton. The proposed device is available in XS, S, M, L, XL, 2XL, 3XL sizes. This proposed device can meet the requirements for Level 3 per ANSI/AAMI PB70:2012.
The proposed devices are disposable medical devices and provided in sterile and blue color.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
operating room personnel during surgical procedures
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical tests were conducted to verify that the proposed device met all design specifications. The subject surgical gown was assessed for performance using the following Standards and Test Methods. The test results demonstrated that the proposed device met its acceptance criteria or testing endpoints.
Study Type: Non-clinical tests
Sample size:
Seam strength: 30 samples
Breaking strength: 30 samples
Tear strength: 30 samples
Lint and other generation in the dry state: 6 samples
Key Results: All tests passed the acceptance criteria, demonstrating the safety and effectiveness of the device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
- Seam strength: 68.46 N (Average result from 30 samples)
- Breaking strength: MD: 120.61N, CD: 88.19N (Average result from 30 samples)
- Tear strength: MD: 60.03N, CD: 39.78N (Average result from 30 samples)
- Lint and other generation in the dry state: 1.9 (Average result from 6 samples)
- Flammability: Class I
- Water Penetration Resistance: =50 cm
- EO and ECH sterilization residual: EO
§ 878.4040 Surgical apparel.
(a)
Identification. Surgical apparel are devices that are intended to be worn by operating room personnel during surgical procedures to protect both the surgical patient and the operating room personnel from transfer of microorganisms, body fluids, and particulate material. Examples include surgical caps, hoods, masks, gowns, operating room shoes and shoe covers, and isolation masks and gowns. Surgical suits and dresses, commonly known as scrub suits, are excluded.(b)
Classification. (1) Class II (special controls) for surgical gowns and surgical masks. A surgical N95 respirator or N95 filtering facepiece respirator is not exempt if it is intended to prevent specific diseases or infections, or it is labeled or otherwise represented as filtering surgical smoke or plumes, filtering specific amounts of viruses or bacteria, reducing the amount of and/or killing viruses, bacteria, or fungi, or affecting allergenicity, or it contains coating technologies unrelated to filtration (e.g., to reduce and or kill microorganisms). Surgical N95 respirators and N95 filtering facepiece respirators are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9, and the following conditions for exemption:(i) The user contacting components of the device must be demonstrated to be biocompatible.
(ii) Analysis and nonclinical testing must:
(A) Characterize flammability and be demonstrated to be appropriate for the intended environment of use; and
(B) Demonstrate the ability of the device to resist penetration by fluids, such as blood and body fluids, at a velocity consistent with the intended use of the device.
(iii) NIOSH approved under its regulation.
(2) Class I (general controls) for surgical apparel other than surgical gowns and surgical masks. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
February 1, 2024
Ammex-Weida (Hubei) Health and Safety Products Co., Ltd % Jarvis Wu Senior Consultant Shanghai Sungo Management Consulting Company Limited 14th Floor, 1500# Central Avenue Shanghai, Shanghai 200122 China
Re: K233183
Trade/Device Name: Surgical Gown (40083) Regulation Number: 21 CFR 878.4040 Regulation Name: Surgical Apparel Regulatory Class: Class II Product Code: FYA Dated: December 29, 2023 Received: December 29, 2023
Dear Jarvis Wu:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device"
1
(https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review. the OS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
2
Sincerely,
Bifeng Qian -S
Bifeng Qian, M.D., Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K233183
Device Name
Surgical Gown (40083)
Indications for Use (Describe)
Surgical Gowns are intended to be worn by operating room personnel during surgical procedures to protect the surgical patient and operating room personnel from the transfer of microorganisms, body fluids and particulate material. This surgical gown meets the requrements of AAMI Level 3 barrier protection for a surgical gown per ANSI/A AMI PB70:2012 Liquid barrier performance and classification of protective apparel and drapes intended for use in health care facilities (AAMI PB70). The Surgical Gowns are single use, disposable medical devices, provided sterile.
Type of Use (Select one or both, as applicable) | |
---|---|
Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(K) Summary K233183
Document prepared date: 2024/1/30
A. Applicant:
Name: Ammex-Weida (Hubei) Health and Safety Products Co., Ltd Address: Southern Industrial Zone (Xinlirenkou), Xiantao, Hubei China, 433011 Contact Person: Melody Wang Tel: +86 13476816925 Mail: office@hborient.com
Submission Correspondent: Primary contact: Mr. Jarvis Wu Shanghai SUNGO Management Consulting Co., Ltd. 14th Floor, Dongfang Building, 1500# Century Ave., Shanghai 200122. China Tel: +86-21-58817802 Email: jiawei.wu@sungoglobal.com Secondary contact: Mr. Raymond Luo 14th Floor, Dongfang Building, 1500# Century Ave., Shanghai 200122, China Tel: +86-21-68828050
Email: zxfda@sungoglobal.com
B. Device:
Trade Name: Surgical Gown Common Name: Surgical Gown Model(s): 40083
Regulatory Information Classification Name: Gown. Surgical Classification: Class II Product code: FYA Regulation Number: 21 CFR 878.4040 Review Panel: Surgical Apparel
C. Predicate device:
K231510 Surgical Gown XIANTAO ZHIBO NON-WOVEN PRODUCTS CO.,LTD
D. Intended use /Indications for Use:
Surgical Gowns are intended to be worn by operating room personnel during surgical procedures to protect the surgical patient and operating room personnel from the transfer of microorganisms, body fluids and particulate material. This surgical gown meets the requirements of AAMI Level 3 barrier protection for a surgical gown per ANSI/AAMI PB70:2012 Liquid barrier performance and classification of protective apparel and drapes intended for use in health care facilities (AAMI PB70). The Surgical Gowns are single use, disposable medical devices, provided sterile.
5
E. Device Description:
The proposed device Surgical Gown is model 40083, its body, sleeve and belt are made of SSMMS non-woven material, and cuff is made of cotton. The proposed device is available in XS, S, M, L, XL, 2XL, 3XL sizes. This proposed device can meet the requirements for Level 3 per ANSI/AAMI PB70:2012.
The proposed devices are disposable medical devices and provided in sterile and blue color.
Table 1 General Comparison | |||
---|---|---|---|
Device | Proposed Device | Predicate Device | Remark |
Manufacturer | Ammex-Weida (Hubei) Health and | ||
Safety Products Co., Ltd | XIANTAO ZHIBO NON-WOVEN | ||
PRODUCTS CO.,LTD. | - | ||
510K number | K233183 | K231510 | - |
Product | |||
Name | Surgical Gown | Surgical Gown | Same |
Classification | Class II Device, FYA (21 | ||
CFR878.4040) | Class II Device, FYA | ||
(21CFR878.4040) | Same | ||
Intended use | |||
/Indications | |||
for Use | Surgical Gowns are intended to be | ||
worn by operating room personnel | |||
during surgical procedures to protect | |||
the surgical patient and operating | |||
room personnel from the transfer of | |||
microorganisms, body fluids and | |||
particulate material. This surgical | |||
gown meets the requirements of | |||
AAMI Level 3 barrier protection for | |||
a surgical gown per ANSI/AAMI | |||
PB70:2012 Liquid barrier | |||
performance and classification of | |||
protective apparel and drapes | |||
intended for use in health care | |||
facilities (AAMI PB70). The | |||
Surgical Gowns are single use, | |||
disposable medical devices, | |||
provided sterile. | Surgical Gown is intended to be | ||
worn by room personnel during | |||
surgical procedures or other invasive | |||
tests to protect both the surgical | |||
patient and operating room | |||
personnel from the transfer of | |||
microorganisms, body fluids and | |||
particulate material. This is single | |||
use, disposable device, provided | |||
sterile. | |||
Per ANSI/AAMI PB70:2012 Liquid | |||
barrier performance and | |||
classification of protective apparel | |||
and drapes intended for use in health | |||
care facilities, the Surgical Gown | |||
met the requirements for Level 3 | |||
classification. | Same | ||
Style | Non-reinforced | Non-reinforced | Same |
Use | Single Use; Disposable | Single Use; Disposable | Same |
Color | Blue | Blue | Same |
Labeling | Conform with 21CFR Part 801 | Conform with 21CFR Part 801 | Same |
Item | Proposed Device(K233183) | Predicate Device(K231510) | Remark |
Size | XS, S, M, L, XL, 2XL, 3XL | S, M, L, XL, XXL, XXXL | Different. |
resolved by | |||
performance | |||
testing | |||
Weight per | |||
square(g) | 45 g/m2 | 50 g/m2 | Different. |
No affect on | |||
safety or | |||
efficacy | |||
Hydrostatic | |||
Pressure(cm) | |||
AATCC-127 | >50 cm | >50 cm | Same |
Water impact | |||
AATCC-42 | ≤1.0 g | ≤1.0 g | Same |
Breaking | |||
strength | MD: 120.61N | ||
CD: 88.19N | MD: 144.87N | ||
CD: 88.89N | Similar | ||
Tearing | |||
strength | MD: 60.03N | ||
CD: 39.78N | MD: 69.61N | ||
CD: 32.25N | Similar | ||
Seam | |||
Strength | >30N | >30N | Same |
Flammability | Class I | Class I | Same |
EO residue | EO ≤ 4mg/d | ||
ECH ≤ 9mg/d | EO ≤ 4mg/d | ||
ECH ≤ 9mg/d | Same | ||
Shelf life | 3 years | 3 years | Same |
Barrier | |||
protection level | Level 3 per AAMI PB 70 | Level 3 per AAMI PB 70 | Same |
Material | SSMMS non-woven, Cotton, | ||
and Nylon + polyester | SMMS non-woven, Cotton, and Nylon | Different | |
Biocompatibility | Under the conditions of the study, the device extract was not cytotoxic. | ||
Under the conditions of the study, the non-polar and polar device | |||
extracts were not found to be an irritant. | |||
Under conditions of the study, the non-polar and polar device | |||
extracts were not found to be a sensitizer. | Same |
F. Comparison with predicate device Table 1 General Comparison
6
Table 2 Safety and Performance Comparison
Analysis
The weight per square (g) ,size and material are slightly different from those of the predicate device. The proposed device has been tested according to ASTM D5587-15, ASTM D5034-09 (2017) and ASTM D1683/D1683M-17(2018) respectively, and met the requirements of the standard.
Difference of the materials will not raise safe and effectiveness concerns. The biocompatibility and performance tests have been conducted to verify the safety and effectiveness of the material. Under the conditions of each study, the subject surgical gowns are non-cytotoxic, non-sensitizing and negligibly irritating per ISO-10993 and have met the requirements of ANSI/AAMI PB70:2012 Liquid Barrier
7
Performance and Classification of Protective Apparel and Drapes Intended for Use in Health Care Facilities for AAMI Level 3 surgical gowns.
G. Summary of Non-Clinical Tests
Non-clinical tests were conducted to verify that the proposed device met all design specifications. The subject surgical gown was assessed for performance using the following Standards and Test Methods. The test results demonstrated that the proposed device met its acceptance criteria or testing endpoints.
Test Item | Test standard | Acceptance Criteria | Result |
---|---|---|---|
Seam strength | |||
ASTM D1683M- | |||
17 Standard Test | |||
Method for | |||
Failure in Sewn | |||
Seams of Woven | |||
Fabrics. | The test was performed | ||
In accordance with | |||
ASTM D1683M-17 | |||
Standard. Test Method | |||
for Seam Strength of | |||
Textile Fabrics (Grab | |||
Test) to evaluate Failure | |||
in Sewn Seams of the test | |||
sample. | ≥30N(7lbf) | ||
per standard | |||
F2407-20 for level 3 | PASS | ||
68.46 N | |||
(Average result from 30 | |||
samples) | |||
Breaking | |||
strength | |||
ASTM D5034-09 | |||
(2017) | |||
Standard Test | |||
Method for | |||
Breaking Strength | |||
and Elongation of | |||
Textile Fabrics | |||
(Grab Test) | The test was performed | ||
In accordance with | |||
D5034-09 (2017) . | |||
Standard. Test Method | |||
for Breaking Strength | |||
and Elongation of Textile | |||
Fabrics (Grab Test) to | |||
evaluate the breaking | |||
strength of the test | |||
sample. | ≥30N(7lbf) | ||
per standard | |||
F2407-20 for level 3 | PASS | ||
MD: 120.61N | |||
CD: 88.19N | |||
(Average result from 30 | |||
samples) | |||
Tear strength(N) | |||
ASTM D5587-15, | |||
Standard Test | |||
Method for | |||
Tearing Strength | |||
of Fabrics by | |||
Trapezoid | |||
Procedure | The test was performed | ||
in accordance with | |||
ASTM D5587: | |||
2015(2019) Standard | |||
Test Method for Tearing | |||
Strength of Fabrics by | |||
Trapezoid Procedure to | |||
evaluate the tearing | |||
strength of the test | |||
sample. | ≥20N | PASS | |
MD: 60.03N | |||
CD: 39.78N | |||
(Average result from 30 | |||
samples) | |||
Lint and other | |||
generation in the | |||
dry state | |||
ISO 9073- | |||
10:2003(E) | The test was performed | ||
in accordance with ISO | |||
9073-10: 2003 Textiles- | |||
Test Methods for | |||
Nonwovens-Part 10: Lint | |||
and Other Particles | |||
Generation in the Dry | |||
State to evaluate the | |||
linting of the test sample. | Log10(particle count) |